jueves, 7 de septiembre de 2017

Our New Thematic Series: Chemical Proteomics

Proteome Science
Impact Factor: 2.360*
Editors-in-Chief: M.Latterich and H. J. Kwon

We are writing to share a selection of articles from our soon to be published ‘Chemical Proteomics’ thematic series.

This series, Guest Edited by Peter Karuso, will aim to highlight the emergence of this new and dynamic field with a focus on chemical proteomics methods and their applications.

Series scope
The recent development of chemical proteomics marks the crossing of proteomics into the discipline of chemistry and is quickly becoming an integrated research engine that bridges the hurdle of identifying protein targets of biologically active small molecules with unknown modes of action. Chemical proteomics provides a high-throughput platform for exploring drug-target-phenotype relationships required for functional proteomics and rapid drug discovery. These efforts are illuminating a new paradigm in drug discovery where prior knowledge of a new chemical entity’s mode of action is not required for the rapid isolation of novel targets.
The series will be published later this year, keep checking the homepage for updates!

Publish with us
Considers all aspects of large-scale and systems studies
High quality peer review: average time to first decision of 40 days

Register to receive the latest articles, straight to your inbox.

Best wishes,

The BioMed Central Team
* The Impact Factor is just one measure used for evaluating the impact of research. For further information on the IF and alternative metrics used to measure the impact of research, please click here.

Proteome Science is affiliated with the Korean Human Proteome Organization (KHUPO).

Follow BioMed Central:
For further information or enquiries please contact Customer Services at:info@biomedcentral.com.
BioMed Central Ltd
236 Gray's Inn Road, London, WC1X 8HB,
United Kingdom.


No hay comentarios:

Publicar un comentario